NEW YORK CITY, November 10, 2016 – Empire State Realty Trust (NYSE: ESRT) announced today that Dr. Martens has signed a long-term lease at 1333 Broadway.
Dr. Martens is a transformed shoe and clothing business that began in 1901 as a modest work-wear boot company. The signature boots now, 115 years later, are known as one of the most culturally relevant brands of the modern era. This iconic brand was born from innovation, authenticity and tradition.
“This transaction adds to the roster of well-known brands in the Broadway corridor,” said Thomas P. Durels, Executive Vice President and Director of Leasing and Operations for ESRT. “This pedestrian plaza serves a mix of tenants and tourists, all while connecting Herald Square and Times Square.”
Keith Fencl of The McDevitt Company represented Dr. Martens in the lease negotiations. Fred Posniak and Shanae Ursini represented ESRT in the transaction.
About Empire State Realty Trust
Empire State Realty Trust, Inc. (NYSE: ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world’s most famous building. Headquartered in New York, New York, the Company’s office and retail portfolio covers 10.1 million rentable square feet, as of September 30, 2016, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut and two in Westchester County, New York; and approximately 707,000 rentable square feet in the retail portfolio.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Federal securities laws. You can identify these statements by our use of the words “assumes,” “believes,” “estimates,” “expects,” “intends,” “plans,” “projects” and similar expressions that do not relate to historical matters. You should exercise caution in interpreting and relying on forward-looking statements, because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond ESRT’s control and could materially affect actual results, performance or achievements. Such factors and risks include, without limitation, a failure of conditions or performance regarding any event or transaction described above, regulatory changes, and other risks and uncertainties described from time to time in ESRT’s filings with the SEC. Except as may be required by law, ESRT does not undertake a duty to update any forward-looking statement, whether as a result of new information, future events or otherwise.
